Skip to main content

Aytu Biopharma, Inc

AYTU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001385818

No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q2 2026, worth $8.25M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Aytu Biopharma, Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
46
−3 vs. Q3 2021
Shares held
3.82M
−424.1K (−10.0%) vs. Q3 2021
Total value
$5.10M
−$7.13M (−58.3%) vs. Q3 2021
New holders
6
9 more added
Sold out
9
15 more reduced

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AYTU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 46 institutions
Q1 2021: 72 institutionsQ2 2021: 61 institutionsQ3 2021: 49 institutionsQ4 2021: 46 institutionsQ1 2022: 44 institutionsQ2 2022: 41 institutionsQ3 2022: 53 institutionsQ4 2022: 42 institutionsQ1 2023: 21 institutionsQ2 2023: 21 institutionsQ3 2023: 22 institutionsQ4 2023: 22 institutionsQ1 2024: 27 institutionsQ2 2024: 27 institutionsQ3 2024: 24 institutionsQ4 2024: 29 institutionsQ1 2025: 31 institutionsQ2 2025: 32 institutionsQ3 2025: 33 institutionsQ4 2025: 39 institutionsQ1 2026: 37 institutionsQ2 2026: 38 institutions
Value heldQ4 2021: $5.10M
Q1 2021: $48.4MQ2 2021: $26.0MQ3 2021: $12.2MQ4 2021: $5.10MQ1 2022: $6.02MQ2 2022: $2.50MQ3 2022: $1.64MQ4 2022: $1.52MQ1 2023: $1.21MQ2 2023: $2.73MQ3 2023: $4.65MQ4 2023: $5.02MQ1 2024: $5.46MQ2 2024: $5.99MQ3 2024: $4.81MQ4 2024: $3.19MQ1 2025: $2.49MQ2 2025: $7.45MQ3 2025: $6.73MQ4 2025: $9.81MQ1 2026: $10.7MQ2 2026: $8.25M
Institutions holding AYTU and their total value by quarter
QuarterHoldersValue
Q2 202638$8.25M
Q1 202637$10.7M
Q4 202539$9.81M
Q3 202533$6.73M
Q2 202532$7.45M
Q1 202531$2.49M
Q4 202429$3.19M
Q3 202424$4.81M
Q2 202427$5.99M
Q1 202427$5.46M
Q4 202322$5.02M
Q3 202322$4.65M
Q2 202321$2.73M
Q1 202321$1.21M
Q4 202242$1.52M
Q3 202253$1.64M
Q2 202241$2.50M
Q1 202244$6.02M
Q4 202146$5.10M
Q3 202149$12.2M
Q2 202161$26.0M
Q1 202172$48.4M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Aytu Biopharma, Inc; share changes are against Q3 2021.

Institutions holding AYTU in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc943,645$1.27M0.00%−39,742−4.0%Reduced
Renaissance Technologies LLC665,069$898.0K0.00%+4,465+0.7%Added
BlackRock Inc.548,724$741.0K0.00%+49,772+10.0%Added
Millennium Management LLC295,779$399.0K0.00%−64,477−17.9%Reduced
Geode Capital Management, LLC257,433$347.0K0.00%00.0%Unchanged
Morgan Stanley190,142$257.0K0.00%−187,780−49.7%Reduced
D. E. Shaw & Co., Inc.109,638$148.0K0.00%−83,721−43.3%Reduced
Commonwealth Equity Services, LLC107,786$145.0K0.00%+68+0.1%Added
State Street Corp97,684$132.0K0.00%00.0%Unchanged
Citadel Advisors LLC98,127$132.0K0.00%+10,558+12.1%Added
Susquehanna Fundamental Investments, LLC71,625$97.0K0.00%−9,239−11.4%Reduced
Occudo Quantitative Strategies LP61,246$83.0K0.01%−12,013−16.4%Reduced
Marshall Wace, LLP52,001$70.0K0.00%+52,001New
Northern Trust Corp48,843$66.0K0.00%−247−0.5%Reduced
Goldman Sachs Group Inc40,867$55.0K0.00%−7,726−15.9%Reduced
Susquehanna International Group, LLP32,028$43.0K0.00%−124,343−79.5%Reduced
Tower Research Capital LLC (TRC)29,116$39.0K0.00%+27,574+1,788.2%Added
Two Sigma Advisers, LP17,430$24.0K0.00%+17,430New
Schonfeld Strategic Advisors LLC17,000$23.0K0.00%−3,200−15.8%Reduced
UBS Group AG14,632$20.0K0.00%+13,050+824.9%Added
Engineers Gate Manager LP12,444$17.0K0.00%+12,444New
Hunter Associates Investment Management LLC10,880$15.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp10,414$14.0K0.00%00.0%Unchanged
Sigma Planning Corp10,116$14.0K0.00%+96+1.0%Added
Squarepoint Ops LLC10,087$14.0K0.00%+10,087New
Advisor Group Holdings, Inc.6,607$9.00K0.00%−2,003−23.3%Reduced
Group One Trading, L.P.3,390$5.00K0.00%−18,604−84.6%Reduced
Wells Fargo & Company2,776$4.00K0.00%−337−10.8%Reduced
Federated Hermes, Inc.3,206$4.00K0.00%+2,542+382.8%Added
Bank of America Corp1,196$2.00K0.00%−5,521−82.2%Reduced
Clearstead Advisors, LLC1,421$2.00K0.00%00.0%Unchanged
IFP Advisors, Inc1,200$2.00K0.00%+600+100.0%Added
Royal Bank of Canada508$1.00K0.00%−76−13.0%Reduced
Focused Wealth Management, Inc209$00.00%00.0%Unchanged
US Bancorp1$00.00%00.0%Unchanged
Harbour Investments, Inc.8$00.00%00.0%Unchanged
Citigroup Inc1$00.00%00.0%Unchanged
Optimum Investment Advisors50$00.00%00.0%Unchanged
Allworth Financial LP1$00.00%00.0%Unchanged
JFS Wealth Advisors, LLC2$00.00%00.0%Unchanged
TCI Wealth Advisors, Inc.1$00.00%00.0%Unchanged
JJJ Advisors Inc.1$00.00%00.0%Unchanged
Aspire Private Capital, LLC5$00.00%00.0%Unchanged
TSFG, LLC21$00.00%00.0%Unchanged
CVA Family Office, LLC1$00.00%+1New
Piper Sandler & Co.49,590––+49,590New
Winton Group Ltd0$00.00%−57,452−100.0%Sold out
HRT Financial LP0$00.00%−27,286−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−15,990−100.0%Sold out
Creative Planning0$00.00%−13,000−100.0%Sold out
Simplex Trading, LLC0$00.00%−723−100.0%Sold out
Stonebridge Capital Advisors LLC0$00.00%−761−100.0%Sold out
FMR LLC0$00.00%−100−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−5−100.0%Sold out
Capital Advisory Group Advisory Services, LLC0$00.00%−1−100.0%Sold out